Retrospective analysis of safety in elderly metastatic or unresectable BRAF V600 melanoma patients treated with Tafinlar (dabrafenib) plus Mekinist (trametinib) and correlation with clinical features and non-elderly patients First published 08/03/2019 Last updated 02/04/2024 EU PAS number:EUPAS28059 Study Finalised